| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.6M | +194.8% |
| R&D Expense | $107.2M | +15.7% |
| SG&A Expense | $33.2M | -4.5% |
| Operating Income | -$138.1M | +5.7% |
| Interest Expense | $540K | +0.0% |
| Pre-tax Income | -$124.8M | +7.4% |
| Income Tax | $1.8M | -4.8% |
| Net Income | -$126.6M | +7.4% |
| EPS (Basic) | -$1.61 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $58.4M | +23.5% |
| Short-term Investments | $130.9M | +4.3% |
| Current Assets | $194.1M | +9.6% |
| Total Assets | $353.2M | -2.1% |
| Current Liabilities | $129.8M | +627.2% |
| Total Liabilities | $191.9M | +9.0% |
| Stockholders' Equity | $161.4M | -12.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$110.1M | -24.7% |
| Capital Expenditures | $154K | -98.9% |
| Investing Cash Flow | $47.5M | -22.3% |
| Financing Cash Flow | $74.6M | +866.7% |
| Free Cash Flow | -$110.3M | -8.0% |
| +30.0% |
| EPS (Diluted) | -$1.61 | +29.1% |